177 related articles for article (PubMed ID: 7086685)
21. Sequential metabolism of salicylamide exclusively to gentisamide 5-glucuronide and not gentisamide sulfate conjugates in single-pass in situ perfused rat liver.
Xu X; Tang BK; Pang KS
J Pharmacol Exp Ther; 1990 Jun; 253(3):965-73. PubMed ID: 2359032
[TBL] [Abstract][Full Text] [Related]
22. Selective inhibition of glucuronidation by 2,2,2-triphenylethyl-UDP in isolated rat hepatocytes: conjugation of harmol, 3,3',5-triiodothyronine, and N-hydroxy-2-acetylaminofluorene.
Noort D; Meijer EA; Visser TJ; Meerman JH; Van der Marel GA; Van Boom JH; Mulder GJ
Mol Pharmacol; 1991 Aug; 40(2):316-20. PubMed ID: 1908549
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneous distribution of conjugation activities of harmol in isolated rat liver cells.
Araya H; Mizuma T; Horie T; Hayashi M; Awazu S
J Pharmacobiodyn; 1984 Sep; 7(9):624-9. PubMed ID: 6098639
[TBL] [Abstract][Full Text] [Related]
24. Intestinal biotransformation of harmol and 1-naphthol in the rat. Further evidence of dose-dependent phase-II conjugation in situ.
Goon D; Klaassen CD
Drug Metab Dispos; 1991; 19(2):340-7. PubMed ID: 1676634
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia impairs conjugation and elimination of harmol in the isolated perfused rat liver.
Angus PW; Mihaly GW; Morgan DJ; Smallwood RA
J Pharmacol Exp Ther; 1987 Mar; 240(3):931-6. PubMed ID: 3559985
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of acetaminophen sulfation by 2,6-dichloro-4-nitrophenol in the perfused rat liver preparation. Lack of a compensatory increase of glucuronidation.
Fayz S; Cherry WF; Dawson JR; Mulder GJ; Pang KS
Drug Metab Dispos; 1984; 12(3):323-9. PubMed ID: 6145559
[TBL] [Abstract][Full Text] [Related]
27. Galactosamine prevents ethinylestradiol-induced cholestasis.
Crocenzi FA; Pellegrino JM; Catania VA; Luquita MG; Roma MG; Mottino AD; Pozzi EJ
Drug Metab Dispos; 2006 Jun; 34(6):993-7. PubMed ID: 16554370
[TBL] [Abstract][Full Text] [Related]
28. Uptake of glucuronides into isolated hepatocytes and their effects on glucuronide and sulphate conjugation.
Norling A; Andersson B; Berggren M; Moldéus P
Acta Pharmacol Toxicol (Copenh); 1978 Oct; 43(4):311-7. PubMed ID: 716948
[TBL] [Abstract][Full Text] [Related]
29. Hepatotoxic effects of estradiol-17 beta-D-glucuronide in the rat and monkey.
Slikker W; Vore M; Bailey JR; Meyers M; Montgomery C
J Pharmacol Exp Ther; 1983 Apr; 225(1):138-43. PubMed ID: 6300372
[TBL] [Abstract][Full Text] [Related]
30. Hormone-induced bile flow and hepatobiliary calcium fluxes are attenuated in the perfused liver of rats made cholestatic with ethynylestradiol in vivo and with phalloidin in vitro.
Hamada Y; Karjalainen A; Bygrave FL
Hepatology; 1995 May; 21(5):1455-64. PubMed ID: 7737653
[TBL] [Abstract][Full Text] [Related]
31. Fasting increases the sensitivity of hepatic harmol glucuronidation to hypoxia.
Elliott SL; Morgan DJ; Smallwood RA
Biochem Pharmacol; 1992 Nov; 44(9):1887-90. PubMed ID: 1449541
[TBL] [Abstract][Full Text] [Related]
32. The availability of inorganic sulphate in blood for sulphate conjugation of drugs in rat liver in vivo. (35S)Sulphate incorporation into harmol sulphate.
Mulder GJ; Scholtens E
Biochem J; 1978 May; 172(2):247-51. PubMed ID: 666743
[TBL] [Abstract][Full Text] [Related]
33. Monohydroxy bile salt sulfates: tauro-3 beta-hydroxy-5-cholenoate-3-sulfate induces intrahepatic cholestasis in rats.
Mathis U; Karlaganis G; Preisig R
Gastroenterology; 1983 Sep; 85(3):674-81. PubMed ID: 6873614
[TBL] [Abstract][Full Text] [Related]
34. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
35. Sulphation of the flavonoids quercetin and catechin by rat liver.
Shali NA; Curtis CG; Powell GM; Roy AB
Xenobiotica; 1991 Jul; 21(7):881-93. PubMed ID: 1776264
[TBL] [Abstract][Full Text] [Related]
36. Effect of 3-methylcholanthrene pretreatment on glucuronidation and sulfation in perfused rat liver.
Hamada N; Gessner T
Drug Metab Dispos; 1975; 3(5):407-16. PubMed ID: 241622
[TBL] [Abstract][Full Text] [Related]
37. Lithocholate glucuronide is a cholestatic agent.
Oelberg DG; Chari MV; Little JM; Adcock EW; Lester R
J Clin Invest; 1984 Jun; 73(6):1507-14. PubMed ID: 6547150
[TBL] [Abstract][Full Text] [Related]
38. Selective inhibition of sulfate conjugation in the rat: pharmacokinetics and characterization of the inhibitory effect of 2,6-dichloro-4-nitrophenol.
Koster H; Halsema I; Scholtens E; Meerman JH; Pang KS; Mulder GJ
Biochem Pharmacol; 1982 May; 31(10):1919-24. PubMed ID: 7104024
[TBL] [Abstract][Full Text] [Related]
39. Carrier-mediated entry of 4-methylumbelliferyl sulfate: characterization by the multiple-indicator dilution technique in perfused rat liver.
Chiba M; Schwab AJ; Goresky CA; Pang KS
Hepatology; 1998 Jan; 27(1):134-46. PubMed ID: 9425929
[TBL] [Abstract][Full Text] [Related]
40. Malaria infection impairs glucuronidation and biliary excretion by the isolated perfused rat liver.
Murdoch RT; Ghabrial H; Mihaly GW; Morgan DJ; Smallwood RA
Xenobiotica; 1991 Dec; 21(12):1571-82. PubMed ID: 1785204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
